116 related articles for article (PubMed ID: 11965357)
1. Effects of antisense oligodeoxynucleotide to the alpha2A-adrenoceptors on the plasma corticosterone level and on elevated plus-maze behavior in rats.
Shishkina GT; Kalinina TS; Sournina NY; Saharov DG; Kobzev VF; Dygalo NN
Psychoneuroendocrinology; 2002 Jul; 27(5):593-601. PubMed ID: 11965357
[TBL] [Abstract][Full Text] [Related]
2. Effects of antisense to the (alpha)2A-adrenoceptors administered into the region of the locus ceruleus on behaviors in plus-maze and sexual behavior tests in sham-operated and castrated male rats.
Shishkina GT; Kalinina TS; Sournina NY; Dygalo NN
J Neurosci; 2001 Jan; 21(2):726-31. PubMed ID: 11160451
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of alpha2A-adrenergic receptor expression in neonatal rat brain by RNA interference or antisense oligonucleotide reduced anxiety in adulthood.
Shishkina GT; Kalinina TS; Dygalo NN
Neuroscience; 2004; 129(3):521-8. PubMed ID: 15541874
[TBL] [Abstract][Full Text] [Related]
4. Influence of neonatal short-term reduction in brainstem alpha2A-adrenergic receptors on receptor ontogenesis, acoustic startle reflex, and prepulse inhibition in rats.
Shishkina GT; Kalinina TS; Popova NK; Dygalo NN
Behav Neurosci; 2004 Dec; 118(6):1285-92. PubMed ID: 15598137
[TBL] [Abstract][Full Text] [Related]
5. Antisense technology reveals the alpha2A adrenoceptor to be the subtype mediating the hypnotic response to the highly selective agonist, dexmedetomidine, in the locus coeruleus of the rat.
Mizobe T; Maghsoudi K; Sitwala K; Tianzhi G; Ou J; Maze M
J Clin Invest; 1996 Sep; 98(5):1076-80. PubMed ID: 8787667
[TBL] [Abstract][Full Text] [Related]
6. Differential behavioural effects of chronic infusion of CRH 1 and CRH 2 receptor antisense oligonucleotides into the rat brain.
Liebsch G; Landgraf R; Engelmann M; Lörscher P; Holsboer F
J Psychiatr Res; 1999; 33(2):153-63. PubMed ID: 10221747
[TBL] [Abstract][Full Text] [Related]
7. Reduced expression of alpha2C-adrenoceptors in rat striatum following antisense oligodeoxynucleotide infusion.
Lu L; Ordway GA
Brain Res Mol Brain Res; 1997 Jul; 47(1-2):267-74. PubMed ID: 9221925
[TBL] [Abstract][Full Text] [Related]
8. Effect of antisense knock-down of alpha(2a)- and alpha(2c)-adrenoceptors on the antinociceptive action of clonidine on trigeminal nociception in the rat.
Wang XM; Zhang ZJ; Bains R; Mokha SS
Pain; 2002 Jul; 98(1-2):27-35. PubMed ID: 12098614
[TBL] [Abstract][Full Text] [Related]
9. Anxiolytic and anti-stress effects of brain prolactin: improved efficacy of antisense targeting of the prolactin receptor by molecular modeling.
Torner L; Toschi N; Pohlinger A; Landgraf R; Neumann ID
J Neurosci; 2001 May; 21(9):3207-14. PubMed ID: 11312305
[TBL] [Abstract][Full Text] [Related]
10. Increased stress-induced adrenocorticotropin response after long-term intracerebroventricular treatment of rats with antisense mineralocorticoid receptor oligodeoxynucleotides.
Reul JM; Probst JC; Skutella T; Hirschmann M; Stec IS; Montkowski A; Landgraf R; Holsboer F
Neuroendocrinology; 1997 Mar; 65(3):189-99. PubMed ID: 9088000
[TBL] [Abstract][Full Text] [Related]
11. Effects of NMDA-R1 antisense oligodeoxynucleotide administration: behavioral and radioligand binding studies.
Zapata A; Capdevila JL; Tarrason G; Adan J; Martínez JM; Piulats J; Trullas R
Brain Res; 1997 Jan; 745(1-2):114-20. PubMed ID: 9037399
[TBL] [Abstract][Full Text] [Related]
12. alpha2A-adrenergic receptors in the rat nucleus locus coeruleus: subcellular localization in catecholaminergic dendrites, astrocytes, and presynaptic axon terminals.
Lee A; Rosin DL; Van Bockstaele EJ
Brain Res; 1998 Jun; 795(1-2):157-69. PubMed ID: 9622618
[TBL] [Abstract][Full Text] [Related]
13. Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats.
Liebsch G; Landgraf R; Gerstberger R; Probst JC; Wotjak CT; Engelmann M; Holsboer F; Montkowski A
Regul Pept; 1995 Oct; 59(2):229-39. PubMed ID: 8584759
[TBL] [Abstract][Full Text] [Related]
14. Different pathways mediated by CCK1 and CCK2 receptors: effect of intraperitonal mrna antisense oligodeoxynucleotides to cholecystokinin on anxiety-like and learning behaviors in rats.
Cohen H; Kaplan Z; Matar MA; Buriakovsky I; Bourin M; Kotler M
Depress Anxiety; 2004; 20(3):139-52. PubMed ID: 15487014
[TBL] [Abstract][Full Text] [Related]
15. Antisense oligodeoxynucleotide complementary to platelet-derived growth factor A-chain messenger RNA inhibits the arterial proliferation in spontaneously hypertensive rats without altering their blood pressures.
Fukuda N; Kubo A; Watanabe Y; Nakayama T; Soma M; Izumi Y; Kanmatsuse K
J Hypertens; 1997 Oct; 15(10):1123-36. PubMed ID: 9350586
[TBL] [Abstract][Full Text] [Related]
16. [Potential anxiolytic role of c-fos antisense oligonucleotide in social-defeated rats].
Lu XH; Li LJ; Li CQ; Luo XG
Hunan Yi Ke Da Xue Xue Bao; 2000 Dec; 25(6):535-8. PubMed ID: 12516397
[TBL] [Abstract][Full Text] [Related]
17. Genetic alteration of the alpha2-adrenoceptor subtype c in mice affects the development of behavioral despair and stress-induced increases in plasma corticosterone levels.
Sallinen J; Haapalinna A; MacDonald E; Viitamaa T; Lähdesmäki J; Rybnikova E; Pelto-Huikko M; Kobilka BK; Scheinin M
Mol Psychiatry; 1999 Sep; 4(5):443-52. PubMed ID: 10523817
[TBL] [Abstract][Full Text] [Related]
18. Effects of testosterone on alpha2A-adrenergic receptor expression in the rat brain.
Dygalo NN; Kalinina TS; Sournina NY; Shishkina GT
Psychoneuroendocrinology; 2002 Jul; 27(5):585-92. PubMed ID: 11965356
[TBL] [Abstract][Full Text] [Related]
19. Intracerebroventricular administration of missense oligodeoxynucleotide induces interleukin-6 mRNA expression in brain and spleen of rats.
Pezeshki G; Schöbitz B; Pohl T; Reul JM
Neurosci Lett; 1996 Oct; 217(2-3):97-100. PubMed ID: 8916081
[TBL] [Abstract][Full Text] [Related]
20. Dual allosteric modulation of opioid antinociceptive potency by α2A-adrenoceptors.
Chabot-Doré AJ; Millecamps M; Naso L; Devost D; Trieu P; Piltonen M; Diatchenko L; Fairbanks CA; Wilcox GL; Hébert TE; Stone LS
Neuropharmacology; 2015 Dec; 99():285-300. PubMed ID: 26254859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
